// App-Quantinova.ai

390 : Colorectal cancer pulmonary metastasis treatment with lung-selective delivery of PAN-class I PI3K inhibitors

Researchers

Presenter

  • Piotr Rychahou

Principal Investigators

  • Younsoo Bae

  • Yekaterina Zaytseva

  • Eun Y. Lee

  • Heidi L. Weiss

  • B. Mark Evers

Medical Centers

  • University of Kentucky Markey Cancer Center and Department of Surgery, Lexington, KY

  • University of Kentucky Markey Cancer Center and Department of Pharmaceutical Sciences, Lexington, KY

  • University of Kentucky Markey Cancer Center, Lexington, KY

  • University of Kentucky Markey Cancer Center and Department of Pathology and Laboratory Medicine, Lexington, KY.

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Colorectal Cancer

  • Lung Cancer

  • Solid malignancies

Biomarkers

  • Phosphatidylinositol 3-kinase

Drug/Treatment

  • Phosphatidylinositol

  • Pictilisib

  • ZSTK474

  • BEZ235

  • PX866

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved